Search





Search





Markets
/
Stocks
/
elan
/

Elanco Animal Health Inc

ELAN

Add to Watchlist

26.370USD

-0.070-0.26%

Close 07-31 16:00（ET）Quotes delayed by 15 min

13.17BMarket Cap

LossP/E TTM

Elanco Animal Health Inc

26.370

-0.070-0.26%

Overview

Financials

Discussions

Analysis

Company

View Detailed Chart

TradingKey Chart

Intraday

30m

Today

-0.26%

5 Days

+5.86%

1 Month

+7.15%

6 Months

+9.51%

Year to Date

+16.53%

1 Year

+92.76%

Key Figures

26.460Open

26.465High

5.19MVolume

LossP/E TTM

21.11P/E Dynamic

--Dividend TTM

1.04%Turnover Ratio

26.460Prev. Close

25.770Low

67.42MTurnover

38.96P/E Static

2.03P/B

0.00%Div Yield TTM

-1.85%ROA

27.72052wk High

1.02Volume Ratio

338.00MNet Profit

499.38MShares

-0.4882EPS TTM

1.70Beta

-3.77%ROE

13.09052wk Low

2.63%Amplitude

47.19%Gross Margin

13.17BMarket Cap

2.40Reward/Risk

2.43%Risk Rate

TradingKey Stock Score of Elanco Animal Health Inc

Currency: USD Updated: 2026-07-31

Key Insights

Elanco Animal Health Inc's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 19 out of 155 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 30.14.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Elanco Animal Health Inc's Score

Industry at a Glance

Industry Ranking

19 / 155

Overall Ranking

58 / 4281

Industry

Pharmaceuticals

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Negative

Elanco Animal Health Inc Highlights

StrengthsRisks

Elanco Animal Health Incorporated is an animal health company delivering products and services to prevent and treat disease in farm animals and pets. The Company's product portfolio is sold in more than 90 countries and serves animals across many species, primarily dogs and cats (collectively, pet health) and cattle, poultry, swine, and sheep (collectively, farm animal). It has a diverse portfolio of products marketed under approximately 200 brands, including products for both pets and farm animals. The Company's global pet health portfolio is focused on parasiticides, vaccines and therapeutics. Its pet health products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its farm animal products include AviPro, Baytril, Catosal, Denagard, Experior, Hemicell, Maxiban/Monteban, Pulmotil, Rumensin, and Surmax. Its customers include consultants, veterinarians, farm animal producers and resellers.

Turnaround to Loss

The company's performance has turned to a loss, with the latest annual loss of USD .

Undervalued

The company’s latest PE is -54.02, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 549.30M shares, decreasing 9.86% quarter-over-quarter.

Held by Brandes Investmen

Star Investor Brandes Investmen holds 2.81M shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of -0.20.

Analyst Rating

Based on 17 analysts

Buy

Current Rating

30.144

Target Price

+14.22%

Upside Space

Elanco Animal Health Inc News

More news coming soon, stay tuned...

Earnings Forecast

Analyst Rating

Based on 17 analysts

Buy

Current Rating

30.144

Target Price

+14.22%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Elanco Animal Health Inc

ELAN

Apple Inc

AAPL

Ge Vernova Inc

GEV

Tapestry Inc

TPR

Verisk Analytics Inc

VRSK

Avantor Inc

AVTR

...

Indicators

Indicators

Sell(1)

Neutral(1)

Buy(4)

Indicators

Value

Direction

MACD(12,26,9)

0.129

Buy

RSI(14)

63.111

Neutral

STOCH(KDJ)(9,3,3)

77.602

Buy

ATR(14)

0.843

High Vlolatility

CCI(14)

118.777

Buy

Williams %R

21.930

Buy

TRIX(12,20)

0.251

Sell

StochRSI(14)

85.682

Overbought

Moving Average

Sell(0)

Neutral(0)

Buy(6)

Indicators

Value

Direction

MA5

26.030

Buy

MA10

25.580

Buy

MA20

25.386

Buy

MA50

24.400

Buy

MA100

23.755

Buy

MA200

23.455

Buy

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Elanco Animal Health Inc Info

Ticker SymbolELAN

CompanyElanco Animal Health Inc

CEOSimmons (Jeffrey N)

Websitehttps://www.elanco.com/

Shareholders

Shareholders

Proportion

Dodge & Cox

15.83%

PRIMECAP Management Company

9.18%

BlackRock Institutional Trust Company, N.A.

8.17%

Fidelity Management & Research Company LLC

7.82%

T. Rowe Price Investment Management, Inc.

7.05%

Other

51.94%

Popular Instruments

FAQs

What is the current price of Elanco Animal Health Inc (ELAN)?



The current price of Elanco Animal Health Inc (ELAN) is 26.39.

What is the symbol of Elanco Animal Health Inc?



The ticker symbol of Elanco Animal Health Inc is ELAN.

What is the 52-week high of Elanco Animal Health Inc?



The 52-week high of Elanco Animal Health Inc is 27.72.

What is the 52-week low of Elanco Animal Health Inc?



The 52-week low of Elanco Animal Health Inc is 13.09.

What is the market capitalization of Elanco Animal Health Inc?



The market capitalization of Elanco Animal Health Inc is 13.18B.

Is Elanco Animal Health Inc (ELAN) currently rated as Buy, Hold, or Sell?



According to analysts, Elanco Animal Health Inc (ELAN) has an overall rating of Buy, with a price target of 30.14.

What is the Earnings Per Share (EPS TTM) of Elanco Animal Health Inc (ELAN)?



The Earnings Per Share (EPS TTM) of Elanco Animal Health Inc (ELAN) is -0.47.